Suppr超能文献

[双相情感障碍中的抗抑郁药]

[Antidepressants in bipolar disorder].

作者信息

Courtet P, Samalin L, Olié E

机构信息

Département d'urgence et post-urgence psychiatrique, CHRU Montpellier, France.

出版信息

Encephale. 2011 Dec;37 Suppl 3:S196-202. doi: 10.1016/S0013-7006(11)70053-7.

Abstract

Whereas mania defines the bipolar disorder, depression is the major challenge of treatment. In general, depressions are more frequent, longer, with a major prognostic impact in terms of disability and suicide. How should we treat a patient with bipolar depression? Antidepressants are the treatment of choice for depression, but not in the bipolar disorder. In this context, we have traditionally accepted that antidepressants are effective but they were inducing a significant risk of destabilization of the bipolar disorder, because of the transitions to mania and rapid cycling. Current data reconsider both the two aspects of this risk-benefit ratio. The effectiveness of antidepressants finally seems very limited, especially after the more recent studies with a robust methodology. Manic switches and rapid cycling may not be increased, particularly with new antidepressants and mood stabilizer combinations. The current literature reminds us that these course's modalities are inherent to the disease, with numerous risk factors, and among them, exposure to antidepressants. Who are the bipolar patients who only get the benefits of antidepressant treatment? Research will tell. They are in any case limited. How to navigate in our treatment strategies ? By choosing first drugs that demonstrated efficacy in bipolar depression. When the situation is more complex, "primum non nocere" should lead to support the prescription of the antidepressant in association with mood stabilizer.

摘要

虽然躁狂是双相情感障碍的典型表现,但抑郁却是治疗的主要挑战。一般来说,抑郁发作更为频繁、持续时间更长,在残疾和自杀方面具有重大的预后影响。我们应该如何治疗双相抑郁患者呢?抗抑郁药是治疗抑郁症的首选药物,但不适用于双相情感障碍。在这种情况下,我们传统上认为抗抑郁药是有效的,但由于会引发躁狂发作和快速循环,它们会带来双相情感障碍病情不稳定的重大风险。目前的数据重新审视了这种风险效益比的两个方面。抗抑郁药的有效性最终似乎非常有限,尤其是在最近采用了严谨方法的研究之后。躁狂发作和快速循环可能不会增加,特别是使用新型抗抑郁药和心境稳定剂联合治疗时。当前的文献提醒我们,这些病程模式是该疾病所固有的,存在众多风险因素,其中包括使用抗抑郁药。哪些双相情感障碍患者能仅从抗抑郁药治疗中获益呢?研究将会给出答案。无论如何,这类患者数量有限。我们应如何制定治疗策略呢?首先应选择已证明对双相抑郁有效的药物。当情况更为复杂时,“首要的是不造成伤害”原则应促使我们支持将抗抑郁药与心境稳定剂联合使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验